EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Betamethasone + Gentamicin, ATC D07CC01, for the period 01.04.26 - 31.03.28 (plus extension option 1x12 months)
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Betamethason + Gentamicin, ATC D07CC01 f. d. Z. 01.04.26 - 31.03.28 (zzgl. Verlängerungsoption 1x12 Monate)
“Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Betamethasone + Gentamicin, ATC D07CC01, for the period 01.04.26 - 31.03.28 (plus extension option 1x12 months)” is a eu-wide public tender. The deadline for offers is Monday, 5 February 2029, in 827 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 February 2029, 827 days left, 12:00
- Published
- 17 February 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
Discount agreement for an active substance for DAK-Gesundheit
- Non-exclusive framework agreements for medicinal products with one active substance
- Contract term begins in April 2026 and ends in March 2028
- An extension option for twelve months is possible
- Companies may join at any time under the same conditions
- Tender documents must be submitted by email
Summary made from the German notice and checked against it; the German original is authoritative.
Contract and procedure
| Duration | 24 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
What stands out
The contract runs for 24 months. The notice links the tender documents directly.
Questions and answers
When is the deadline for offers?
Until Monday, 5 February 2029, 827 days left. The exact time and how to submit are in the original notice, which is authoritative.
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
Dates of this tender
| Published | Tuesday, 17 February 2026 |
|---|---|
| Deadline | Monday, 5 February 2029, 12:00 |
| Tender validity ends (calculated) | Wednesday, 7 March 2029 |
Service by CPV code
- 33600000 Pharmaceutical products
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.